Results 71 to 80 of about 224,706 (187)

Test–retest reliability of clinical accommodative measures in adolescents

open access: yesOptometry and Vision Science, Volume 103, Issue 2, February 2026.
ABSTRACT Purpose To determine long‐term (3 months) test–retest reliability of accommodative testing in adolescents with normal accommodative amplitude. Methods Participants aged 12 years to <17.5 years with normal accommodative amplitude (minimum of 11 diopters [D]) and binocular vision were enrolled.
Angela M. Chen   +11 more
wiley   +1 more source

Serum selenium status in Graves' disease with and without orbitopathy: A case-control study [PDF]

open access: yes, 2014
OBJECTIVE: Selenium is effective in improving quality of life and reducing the progression of active Graves' orbitopathy. The effect of correcting relative selenium deficiency on improving Graves' orbitopathy is unknown, as baseline selenium levels have ...
Khong, JJ   +7 more
core   +1 more source

Thyroid associated orbitopathy

open access: yesIndian Journal of Ophthalmology, 2012
Thyroid associated orbitopathy, also known as Graves′ orbitopathy, is typically a self-limiting autoimmune process associated with dysthyroid states.
Rajat Maheshwari, Ezekiel Weis
doaj   +1 more source

Graves` orbitopathy: frequency of ocular hypertension and glaucoma

open access: yes, 2009
Purpose To determine the relationship between ocular hypertension and glaucoma in patients with Graves` orbitopathy. Methods A total of 107 patients with a diagnosis of Graves` orbitopathy, followed at the Oculoplasty sector of the University Hospital ...
CRUZ, A. A. V.   +3 more
core   +1 more source

Exploring tear fluid biomarkers and the ocular surface in thyroid eye disease

open access: yesActa Ophthalmologica, Volume 104, Issue 1, Page e28-e38, February 2026.
Abstract Purpose To examine ocular surface changes and inflammatory tear fluid biomarkers in patients with thyroid eye disease (TED). Methods We included 106 Graves' disease (GD) patients (36 without TED, 32 with active and 38 with inactive TED) and 106 age‐ and sex‐matched healthy subjects for ophthalmological evaluation, including ocular surface ...
Mikael Thomassen Neset   +13 more
wiley   +1 more source

Upper eyelid retraction disclosed after edrophonium chloride administration in a patient with Graves&#39; orbitopathy and myasthenia gravis

open access: yesClinical Ophthalmology, 2012
Hyera Kang,1,2 Yasuhiro Takahashi,1 Masayoshi Iwaki,1 Shinichi Asamura,3 Hirohiko Kakizaki,11Department of Ophthalmology, Aichi Medical University, Nagakute, Aichi, Japan; 2Department of Ophthalmology, Presbyterian Medical Center, Jeonju, Korea ...
Kang H   +4 more
doaj  

Alemtuzumab-induced thyroid eye disease successfully treated with a single low dose of rituximab

open access: yesEuropean Thyroid Journal
Introduction: Secondary thyroid autoimmunity, especially Graves’ disease (GD), frequently develops in patients with multiple sclerosis (MS) following alemtuzumab treatment (ALTZ; anti-CD52). Thyroid eye disease (TED) can also develop, and rituximab (RTX;
Ilaria Muller   +10 more
doaj   +1 more source

Single‐Cell RNA Sequencing of Thyroid Tissues Reveals Pathogenesis of Graves' Disease

open access: yesAdvanced Science, Volume 13, Issue 1, 5 January 2026.
Using single‐cell RNA sequencing and TCR profiling, this study constructed an immune cell atlas in thyroid tissue of Graves’ disease (GD), revealing dominant IFN‐γ‐secreting CD4+ T cells, expanded Tph and CD11c+ B cells, and enriched T/NK cells. Notably, GD thyroid follicular cells (TFCs) activated γδ T cells, which recruited cDC1 cells, suggesting a ...
Xiaoyi Zhou   +18 more
wiley   +1 more source

Mechanistic Pathways of Selenium in the Treatment of Graves' Disease and Graves' Orbitopathy

open access: yes, 2018
Based on the role of oxidative stress in the pathogenesis of Graves' hyperthyroidism and Graves' orbitopathy, the use of the antioxidant agent selenium has been proposed and several studies on the subject have been conducted, both in vitro and in vivo ...
Leo, Marenza   +3 more
core   +1 more source

Association of Individual or Family History of Autoimmune Disease With Future Development of Type 1 Diabetes

open access: yesDiabetes/Metabolism Research and Reviews, Volume 42, Issue 1, January 2026.
ABSTRACT Timely diagnosis of type 1 diabetes (T1D), especially in high‐risk populations, is crucial for preventing serious health complications. T1D is a chronic progressive autoimmune disease that has presymptomatic stages that can be identified through the detection of islet autoantibodies. Given that T1D is associated with other autoimmune diseases,
Nick Thomas   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy